Combination effects of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) and individual chemotherapeutics in non-small cell lung cancer (NSCLC) cells with and without sensitizing-EGFR mutations

被引：0
|
作者：
Tsai, C. [1 ]
Chang, K. [1 ]
Chiu, C. [1 ]
Hsiao, S. [1 ]
机构：
[1] Taipei Vet Gen Hosp, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18062
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CONSISTENT LOW DEGREE ANTAGONISM OF COMBINED EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITOR (EGFR-TKI) AND INDIVIDUAL CHEMOTHERAPEUTIC AGENTS IN NON-SMALL CELL LUNG CANCER (NSCLC) CELLS HARBORING SENSITIZING-EGFR MUTATIONS
    Tsai, Chun-Ming
    Chang, K. -T.
    Chiu, Chao-Hua
    Hsiao, Shih-Yin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S733 - S734
  • [2] Rare and complex mutations of epidermal growth factor receptor (EGFR) and efficacy of tyrosine kinase inhibitor (TKI) in patients with non-small cell lung cancer (NSCLC).
    Keam, Bhumsuk
    Kim, Dong-Wan
    Park, Jin Hyun
    Lee, Jeong-Ok
    Kim, Tae Min
    Lee, Se-Hoon
    Jeon, Yoon-Kyung
    Chung, Doo Hyun
    Heo, Dae Seog
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] KRAS mutational status and sensitivity to a reversible epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in EGFR wild type (WT) advanced non-small cell lung cancer (NSCLC) patients (pts)
    Metro, Giulio
    Duranti, Simona
    Chiari, Rita
    Bennati, Chiara
    Molica, Carmen
    Curra, Maria Francesca
    Scafati, Chiara
    Siggillino, Annamaria
    Flacco, Antonella
    Marcomigni, Luca
    Ludovini, Vienna
    Minotti, Vincenzo
    Crino, Lucio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Role of chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) rechallenge in small cell transformation after EGFR-TKI failure: a case report
    Lee, Sanghun
    Joo, Jeonghyun
    Kwak, Minah
    Sohn, Kicheul
    Chon, Songha
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 3943 - 3947
  • [5] EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR (EGFR-TKI) RELATED INTERSTITIAL LUNG DISEASE IN TAIWANESE PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Chiang, Chi-Lu
    Tsai, Chun-Ming
    Lee, Yu-Chin
    Chiu, Chao-Hua
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S592 - S592
  • [6] SYNERGISTIC EFFECT OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN EGFR-TKI RESISTANT NON-SMALL CELL LUNG CANCER CELL LINES
    Han, X.
    Zhang, N.
    Yao, J.
    Shi, Y.
    [J]. ANNALS OF ONCOLOGY, 2015, 26
  • [7] Combined epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor and chemotherapy in non-small-cell lung cancer: Chemo-refractoriness of cells harboring sensitizing-EGFR mutations in the presence of gefitinib
    Tsai, Chun-Ming
    Chen, Jen-Ting
    Chiu, Chao-Hua
    Lai, Chun-Liang
    Hsiao, Shih-Yin
    Chang, Kuo-Ting
    [J]. LUNG CANCER, 2013, 82 (02) : 305 - 312
  • [8] Effectiveness Of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors On Non-Small Cell Lung Cancer Harboring Rare EGFR Mutations
    Chang, L. -C.
    Chen, K. -Y.
    Shih, J. -Y.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [9] Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis
    Lee, H. J.
    Jeong, G. H.
    Li, H.
    Kim, M. S.
    Kim, J. S.
    Park, S. J.
    Han, Y. J.
    Lee, K. H.
    Kronbichler, A.
    Hong, S. H.
    Ghayda, R. A.
    Luchini, C.
    Nottegar, A.
    Koyanagi, A.
    Smith, L.
    Jacob, L.
    Dragioti, E.
    Radua, J.
    Cargnin, S.
    Terrazzino, S.
    Thompson, T.
    Yon, D. K.
    Lee, S. W.
    Yang, J. M.
    Wasuwanich, P.
    Shin, J. I.
    Gamerith, G.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (20) : 6232 - 6244
  • [10] The plasma ctDNA monitoring during epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial)
    Usui, K.
    Yokoyama, T.
    Kisohara, A.
    Mori, Y.
    Takeda, Y.
    Ishida, H.
    Kusano, N.
    Kishi, K.
    Katsushima, U.
    Kuwako, T.
    Aono, H.
    Shikama, Y.
    Minato, K.
    Matsushima, H.
    Uemura, K.
    Ohashi, Y.
    Kunitoh, H.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 514 - 514
12345